Lithium, but not valproate, induces the serine/threonine phosphatase activity of protein phosphatase 2A in the rat brain, without affecting its expression

Journal of Neural Transmission

Volumn 110, Issue 4, 2003, Pages 413-425

  Tsuji, S ^a   Morinobu, S ^a   Tanaka, K ^a   Kawano, K ^a   Yamawaki, S ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Dephosphorylation; Lithium; Protein phosphatase 2A (PP2A); Serine threonine phosphatase activity; Valproate

Indexed keywords

LITHIUM; PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 2A; SERINE THREONINE PHOSPHATASE; SODIUM CHLORIDE; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CONTROLLED STUDY; DEPHOSPHORYLATION; DEVELOPMENT; ENZYME ACTIVITY; ENZYME INDUCTION; FRONTAL CORTEX; GENE EXPRESSION; HIPPOCAMPUS; IMMUNOREACTIVITY; MALE; NERVE FUNCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; BRAIN; ENZYME ACTIVATION; ENZYME INDUCTION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; LITHIUM CHLORIDE; MALE; PHOSPHOPROTEIN PHOSPHATASE; RATS; RATS, SPRAGUE-DAWLEY; VALPROIC ACID;

EID: 0037390480     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00702-002-0798-0     Document Type: Article

References (40)

1. Alberts AS, Deng T, Lin A, Meinkoth JL, Schonthal A, Mumby MC, Karin M, Feramisco JR (1993) Protein phosphatase 2A potentiates activity of promoters containing AP-1-binding elements. Mol Cell Biol 13: 2104-2112
2. Berridge MJ, Downes CP, Hanley MR (1982) Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem J 206: 587-595
3. Bito H, Deisseroth K. Tsien RW (1996) CREB phosphorylation and dephosphorylation: a Ca(2+)- and stimulus duration-dependent switch for hippocampal gene expression. Cell 87: 1203-1214
4. Chen G, Yuan P, Hawver DB, Potter WZ, Manji HK (1997) Increase in AP-1 transcription factor DNA binding activity by valproic acid. Neuropsychopharmacology 16: 238-245
5. Chen G, Zeng WZ, Yuan PX, Huang LD, Jiang YM, Zhao ZH, Manji HK (1999) The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem 72: 879-882
6. Chen G, Masana MI, Manji HK (2000) Lithium regulates PKC-mediated intracellular cross-talk and gene expression in the CNS in vivo. Bipolar Disord 2: 217-236
7. Chen RW, Chuang DM (1999) Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity. J Biol Chem 274: 6039-6042
8. Chiang CW, Harris G, Ellig C, Masters SC, Subramanian R, Shenolikar S, Wadzinski BE, Yang E (2001) Protein phosphatase 2A activates the proapoptotic function of BAD in interleukin-3-dependent lymphoid cells by a mechanism requiring 14-3-3 dissociation. Blood 97: 1289-1297
9. Cieslik K, Zembowicz A, Tang JL, Wu KK (1998) Transcriptional regulation of endothelial nitric-oxide synthase by lysophosphatidylcholine. J Biol Chem 273: 14885-14890
10. Feschenko MS, Stevenson E, Nairn AC, Sweadner KJ (2002) A novel cAMP-stimulated pathway in protein phosphatase 2A activation. J Pharmacol Exp Ther 302: 111-118
11. Fladmark KE, Brustugun OT, Hovland R, Boe R, Gjertsen BT, Zhivotovsky B, Doskeland SO (1999) Ultrarapid caspase-3 dependent apoptosis induction by serine/threonine phosphatase inhibitors. Cell Death Differ 6: 1099-1108
12. Fukumoto T, Morinobu S, Okamoto Y, Kagaya A, Yamawaki S (2001) Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology (Berl) 158: 100-106
13. Garcia A, Cayla X, Sontag B (2000) Protein phosphatase 2A: a definite player in viral and parasitic regulation. Microbes Infect 2: 401-407
14. Ishida A, Kameshita I, Fujisawa H (1998) A novel protein phosphatase that dephosphorylates and regulates Ca2+/calmodulin-dependent protein kinase II. J Biol Chem 273: 1904-1910
15. Jensen JB, Mikkelsen JD, Mork A (2000) Increased adenylyl cyclase type 1 mRNA, but not adenylyl cyclase type 2 in the rat hippocampus following antidepressant treatment. Eur Neuropsychopharmacol 10: 105-111
16. Kang HS, Choi I (2001) Protein phosphatase 2A modulates the proliferation of human multiple myeloma cells via regulation of the production of reactive oxygen intermediates and anti-apoptotic factors. Cell Immunol 213: 34-44
17. Katayose Y, Li M, Al-Murrani SW, Shenolikar S, Damuni Z (2000) Protein phosphatase 2A inhibitors, I(1)(PP2A) and I(2)(PP2A), associate with and modify the substrate specificity of protein phosphatase 1. J Biol Chem 275: 9209-9214
18. Kremmer E, Ohst K, Kiefer J, Brewis N, Walter G (1997) Separation of PP2A core enzyme and holoenzyme with monoclonal antibodies against the regulatory A subunit: abundant expression of both forms in cells. Mol Cell Biol 17: 1692-1701
19. Li M, Makkinje A, Damuni Z (1996a) Molecular identification of I1PP2A, a novel potent heat-stable inhibitor protein of protein phosphatase 2A. Biochemistry 35: 6998-7002
20. Li M, Makkinje A, Damuni Z (1996b) The myeloid leukemia-associated protein SET is a potent inhibitor of protein phosphatase 2A. J Biol Chem 271: 11059-11062
21. Malenka RC (1994) Synaptic plasticity in the hippocampus: LTP and LTD. Cell 78: 535-538
22. Manji HK, Chen G, Shimon H, Hsiao JK, Potter WZ, Belmaker RH (1995a) Guanine nucleotide-binding proteins in bipolar affective disorder. Effects of long-term lithium treatment. Arch Gen Psychiatry 52: 135-144
23. Manji HK, Potter WZ, Lenox RH (1995b) Signal transduction pathways. Molecular targets for lithium's actions. Arch Gen Psychiatry 52: 531-543
24. Manji HK, Moore GJ, Rajkowska G, Chen G (2000) Neuroplasticity and cellular resilience in mood disorders. Mol Psychiatry 5: 578-593
25. Millward TA, Zolnierowicz S, Hemmings BA (1999) Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem Sci 24: 186-191
26. Nagase T, Murakami T, Nozaki H, Inoue R, Nishito Y, Tanabe O, Usui H, Takeda M (1997) Tissue and subcellular distributions, and characterization of rat brain protein phosphatase 2A containing a 72-kDa delta/B″ subunit. J Biochem (Tokyo) 122: 178-187
27. Runden E, Seglen PO, Haug FM, Ottersen OP, Wieloch T, Shamloo M, Laake JH (1998) Regional selective neuronal degeneration after protein phosphatase inhibition in hippocampal slice cultures: evidence for a MAP kinase-dependent mechanism. J Neurosci 18: 7296-7305
28. Sands SA, Guerra V, Morilak DA (2000) Changes in tyrosine hydroxylase mRNA expression in the rat locus coeruleus following acute or chronic treatment with valproic acid. Neuropsychopharmacology 22: 27-35
29. Sidhu JS, Omiecinski CJ (1997) An okadaic acid-sensitive pathway involved in the phenobarbital-mediated induction of CYP2B gene expression in primary rat hepatocyte cultures. J Pharmacol Exp Ther 282: 1122-1129
30. Sim AT, Ratcliffe E, Mumby MC, Villa-Moruzzi E, Rostas JA (1994) Differential activities of protein phosphatase types 1 and 2A in cytosolic and particulate fractions from rat forebrain. J Neurochem 62: 1552-1559
31. Spencer CM, Houpt TA (2001) Dynamics of c-fos and ICER mRNA expression in rat forebrain following lithium chloride injection. Brain Res Mol Brain Res 93: 113-126
32. Strack S, Westphal RS, Colbran RJ, Ebner FF, Wadzinski BE (1997) Protein serine/threonine phosphatase 1 and 2A associate with and dephosphorylate neurofilaments. Brain Res Mol Brain Res 49: 15-28
33. Suuronen T, Kolehmainen P, Salminen A (2000) Protective effect of L-deprenyl against apoptosis induced by okadaic acid in cultured neuronal cells. Biochem Pharmacol 59: 1589-1595
34. Takahashi H, Higuchi H, Shimizu T (2000) Severe lithium toxicity induced by combined levofloxacin administration. J Clin Psychiatry 61: 949-950
35. Takahashi J, Tanaka K, Morinobu S. Fujimaki K, Li ST, Kato K, Ohkawa M, Yamawaki S, Kato N (2001) Influence of restraint stress on the expression and the serine/threonine phosphatase activity of calcineurin in the rat brain. Synapse 40: 130-136
36. Tanaka K, Takahashi J, Morinobu S, Fujimaki K, Tsuji S, Kato K, Ohkawa M, Yamawaki S, Kato N (2002) Imipramine, but not lithium, induces the serine/threonine phosphatase activity of calcineurin without affecting its mRNA expression in the rat brain. Psychopharmacology (Berl) 162: 339-344
37. Tian L, Knaus HG, Shipston MJ (1998) Glucocorticoid regulation of calcium-activated potassium channels mediated by serine/threonine protein phosphatase. J Biol Chem 273: 13531-13536
38. Turowski P, Favre B, Campbell KS, Lamb NJ, Hemmings BA (1997) Modulation of the enzymatic properties of protein phosphatase 2A catalytic subunit by the recombinant 65-kDa regulatory subunit PR65alpha. Eur J Biochem 248: 200-208
39. Wadzinski BE, Wheat WH, Jaspers S, Peruski LF Jr, Lickteig RL, Johnson GL, Klemm DJ (1993) Nuclear protein phosphatase 2A dephosphorylates protein kinase A-phosphorylated CREB and regulates CREB transcriptional stimulation. Mol Cell Biol 13: 2822-2834
40. Wiborg O, Kruger T, Jakobsen SN (1999) Region-selective effects of long-term lithium and carbamazepine administration on cyclic AMP levels in rat brain. Pharmacol Toxicol 84: 88-93